Cargando…

The 10th International Conference on cGMP 2022: recent trends in cGMP research and development—meeting report

Increasing cGMP is a unique therapeutic principle, and drugs inhibiting cGMP-degrading enzymes or stimulating cGMP production are approved for the treatment of various diseases such as erectile dysfunction, coronary artery disease, pulmonary hypertension, chronic heart failure, irritable bowel syndr...

Descripción completa

Detalles Bibliográficos
Autores principales:	Friebe, Andreas, Kraehling, Jan R., Russwurm, Michael, Sandner, Peter, Schmidtko, Achim
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Berlin Heidelberg 2023
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10338386/ https://www.ncbi.nlm.nih.gov/pubmed/37079081 http://dx.doi.org/10.1007/s00210-023-02484-8

Ejemplares similares

cGMP: a unique 2nd messenger molecule – recent developments in cGMP research and development
por: Friebe, Andreas, et al.
Publicado: (2019)

Meeting report of the 8(th) International Conference on cGMP “cGMP: generators, effectors, and therapeutic implications” at Bamberg, Germany, from June 23 to 25, 2017
por: Friebe, Andreas, et al.
Publicado: (2017)

cGMP-dependent signaling pathways in spinal pain processing
por: Schmidtko, Achim, et al.
Publicado: (2009)

Analysis of cGMP signalling with transgenic mice expressing FRET-based cGMP sensors
por: Wen, Lai, et al.
Publicado: (2013)

Direct activation of PDE5 by cGMP: long-term effects within NO/cGMP signaling
por: Mullershausen, Florian, et al.
Publicado: (2003)

NO-dependent cGMP signalling in neurons and astrocytes
por: Giesen, Jan, et al.
Publicado: (2015)

Structural and mechanistic insights into cGMP signaling
por: Rauch, Annika, et al.
Publicado: (2009)

Inhibition of the TGFβ signalling pathway by cGMP and cGMP‐dependent kinase I in renal fibrosis
por: Schinner, Elisabeth, et al.
Publicado: (2017)

Role of NO/cGMP signalling in VEGF-mediated angiogenesis
por: Jäger, Ronald, et al.
Publicado: (2011)

NO/cGMP signalling in platelets
por: Schinner, Elisabeth, et al.
Publicado: (2009)

cGMP and cardiac hypertrophy
por: Perera, Ruwan K, et al.
Publicado: (2015)

cGMP signals in smooth muscle cells and cardiac myocytes
por: Krawutschke, Christian, et al.
Publicado: (2011)

cGMP kinase I regulates glucagon release
por: Leiss, Veronika, et al.
Publicado: (2009)

Transient kinetics of a cGMP-dependent cGMP-specific phosphodiesterase from Dictyostelium discoideum
Publicado: (1984)

PDE5 says NO to cGMP
por: LeBrasseur, Nicole
Publicado: (2003)

cGMP steers axons home
por: LeBrasseur, Nicole
Publicado: (2002)

A novel pathway of cGMP
por: Kuhn, Michaela, et al.
Publicado: (2011)

The role of cGMP and PKG in cardioprotection
por: Downey, James M, et al.
Publicado: (2009)

NO-cGMP signalling and cancer therapy
por: Bian, Ka, et al.
Publicado: (2013)

Role of cGMP in fat and metabolism
por: Pfeifer, Alexander, et al.
Publicado: (2013)

cGMP Signaling in Photoreceptor Degeneration
por: Li, Shujuan, et al.
Publicado: (2023)

cGMP Imaging in Brain Slices Reveals Brain Region-Specific Activity of NO-Sensitive Guanylyl Cyclases (NO-GCs) and NO-GC Stimulators
por: Peters, Stefanie, et al.
Publicado: (2018)

cGMP elevation: new treatment options for lower urinary tract disorders
por: Sandner, Peter
Publicado: (2009)

Meeting abstracts from the 10th International Conference on cGMP: Generators, Effectors and Therapeutic Implications
Publicado: (2023)

Elevated retinal cGMP is not associated with elevated circulating cGMP levels in a canine model of retinitis pigmentosa
por: Occelli, Laurence M., et al.
Publicado: (2022)

Vascular and renal function of cGMP signalling
por: Schlossmann, Jens, et al.
Publicado: (2011)

Role of cGMP/PKG in fat tissue
por: Pfeifer, Alexander
Publicado: (2011)

cGMP becomes a drug target
por: Schlossmann, Jens, et al.
Publicado: (2012)

NO-H(2)S interactions involve cGMP
por: Papapetropoulos, Andreas
Publicado: (2013)

cGMP kinase: past, presence and future
por: Hofmann, Franz, et al.
Publicado: (2013)

Natriuretic peptides and cGMP in metabolic disease
por: Collins, Sheila
Publicado: (2015)

Modulating cGMP to Treat Lung Diseases
por: Ghofrani, Hossein-Ardeschir, et al.
Publicado: (2009)

cGMP at the centre of attention: emerging strategies for activating the cardioprotective PKG pathway
por: Park, Min, et al.
Publicado: (2018)

Natriuretic Peptides/cGMP/cGMP-Dependent Protein Kinase Cascades Promote Muscle Mitochondrial Biogenesis and Prevent Obesity
por: Miyashita, Kazutoshi, et al.
Publicado: (2009)

Forty-five years of cGMP research in Dictyostelium: understanding the regulation and function of the cGMP pathway for cell movement and chemotaxis
por: van Haastert, Peter J. M., et al.
Publicado: (2021)

Mind the gap (junction): cGMP induced by nitric oxide in cardiac myocytes originates from cardiac fibroblasts
por: Menges, Lukas, et al.
Publicado: (2019)

Meeting abstracts from the 9th International Conference on cGMP: Generators, Effectors and Therapeutic Implications
Publicado: (2019)

The ANP/cGMP/cGMP-dependent protein kinase pathway counteracts Angiotensin II-stimulated calcium mobilization in cardiac myocytes
por: Klaiber, Michael, et al.
Publicado: (2009)

Extracellular cGMP Modulates Learning Biphasically by Modulating Glycine Receptors, CaMKII and Glutamate-Nitric Oxide-cGMP Pathway
por: Cabrera-Pastor, Andrea, et al.
Publicado: (2016)

The cGMP system in normal and degenerating mouse neuroretina: New proteins with cGMP interaction potential identified by a proteomics approach
por: Rasmussen, Michel, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_d1pag0sf8a84jfiu445qt6i9j0